Microlin Bio (Microlin Bio) COGS-to-Revenue : 0.00 (As of Sep. 2015)

View and export this data going back to 2014. Start your Free Trial

What is Microlin Bio COGS-to-Revenue?

Microlin Bio's Cost of Goods Sold for the three months ended in Sep. 2015 was $0.00 Mil. Its Revenue for the three months ended in Sep. 2015 was $0.00 Mil.

Microlin Bio's COGS to Revenue for the three months ended in Sep. 2015 was 0.00.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Microlin Bio's Gross Margin % for the three months ended in Sep. 2015 was N/A%.

Microlin Bio COGS-to-Revenue Historical Data

The historical data trend for Microlin Bio's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Microlin Bio COGS-to-Revenue Chart

Microlin Bio Annual Data

Trend

Dec12

Dec13

Dec14

COGS-to-Revenue

Microlin Bio Quarterly Data
	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15
COGS-to-Revenue	Get a 7-Day Free Trial									-	-	-	-	-

Microlin Bio COGS-to-Revenue Calculation

Microlin Bio's COGS to Revenue for the fiscal year that ended in Dec. 2014 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	0	/	0.008
	=	0.00

Microlin Bio's COGS to Revenue for the quarter that ended in Sep. 2015 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	0	/	0
	=

Microlin Bio (GREY:MICB) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Microlin Bio's Gross Margin % for the three months ended in Sep. 2015 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	0 / 0
	=	N/A %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Microlin Bio COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Microlin Bio's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Microlin Bio (Microlin Bio) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Microlin Bio Inc (GREY:MICB) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

http://www.microlinbio.com

MicroLin Bio Inc is engaged in the healthcare sector. It is a therapeutic and diagnostic company focusing on microRNA and its role in oncology. MicroRNAs represent a class of diagnostics and therapeutics that are more effective in the diagnosis and treatment of cancer, with the potential for mitigating side effects in comparison with conventional small molecule drugs or biologics. The company's properties include molecular diagnostics and companion tests, cancer therapeutics, and delivery platform technology. Molecular diagnostics & companion tests include tests such as Lumira, Omira, Colomira, and Promira. Cancer therapeutics includes lumiralin, omiralin, colomiralin, and promirali.

Microlin Bio (Microlin Bio) Headlines

No Headlines